D
Mineralys Therapeutics, Inc. MLYS
$14.25 $0.755.56%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -48.95M -56.34M -41.01M -31.51M -24.39M
Total Depreciation and Amortization 15.00K 11.00K 9.00K 8.00K --
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 1.80M 427.00K 25.00K -318.00K -609.00K
Change in Net Operating Assets -19.71M 5.72M 10.83M 12.68M -3.98M
Cash from Operations -66.84M -50.19M -30.15M -19.14M -28.98M
Capital Expenditure 0.00 -37.00K 0.00 -59.00K --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 83.57M 79.64M 7.74M -55.89M -8.09M
Cash from Investing 83.57M 79.61M 7.74M -55.95M -8.09M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 137.00K 40.00K 132.00K 116.27M 74.00K
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -47.00K -41.00K -284.00K -63.00K --
Cash from Financing 90.00K -1.00K -152.00K 116.21M 74.00K
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 16.82M 29.42M -22.56M 41.11M -37.00M
Weiss Ratings